Ignite Creation Date:
2025-12-26 @ 11:45 AM
Ignite Modification Date:
2025-12-26 @ 11:45 AM
Study NCT ID:
NCT00090116
Status:
COMPLETED
Last Update Posted:
2012-03-05
First Post:
2004-08-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease
Sponsor:
Forest Laboratories
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-03
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-08-24
First Submit QC Date:
None
Study First Post Date:
2004-08-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-01
Last Update Post Date:
2012-03-05
Last Update Post Date Type:
ESTIMATED